Daewoong Co., Ltd.
Research Daewoong Co., Ltd. (003090.KS) on Bullrun: market cap KRW 659.98B, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003090.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 659.98B
- Dividend yield1.3%
- Financial periodQ2 2026
- RevenueKRW 570.82B
- Net incomeKRW 34.13B
- Free cash flow-KRW 8.65B
- Gross margin55.0%
Valuation Snapshot
latest market cap is KRW 659.98B; dividend yield is 1.3%.
Peer valuation comparison
Latest dividend yield is 1.28% versus a Healthcare sector median of 2.4% (46.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 659.98B | n/a | 1.3% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 1.3%.
About Daewoong Co., Ltd.
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd.
ETFs that hold Daewoong Co., Ltd.
US-listed ETFs
Daewoong Co., Ltd. is held by 22 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daewoong Co., Ltd.'s market cap?
Daewoong Co., Ltd.'s market capitalization is KRW 659.98B.
Does Daewoong Co., Ltd. pay a dividend?
Daewoong Co., Ltd. has a dividend yield of 1.3%.
What does Daewoong Co., Ltd. do?
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, South Korea.